X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Lupin Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs LUPIN LTD - Comparison Results

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB LUPIN LTD UNICHEM LAB/
LUPIN LTD
 
P/E (TTM) x 33.2 23.4 142.2% View Chart
P/BV x 3.5 3.2 110.5% View Chart
Dividend Yield % 0.5 0.8 68.6%  

Financials

 UNICHEM LAB   LUPIN LTD
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
LUPIN LTD
Mar-17
UNICHEM LAB/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs3341,750 19.1%   
Low Rs1741,384 12.6%   
Sales per share (Unadj.) Rs146.9387.4 37.9%  
Earnings per share (Unadj.) Rs11.956.6 21.0%  
Cash flow per share (Unadj.) Rs16.276.8 21.1%  
Dividends per share (Unadj.) Rs2.007.50 26.7%  
Dividend yield (eoy) %0.80.5 164.5%  
Book value per share (Unadj.) Rs105.1298.9 35.2%  
Shares outstanding (eoy) m90.84451.58 20.1%   
Bonus/Rights/Conversions ESOPESOPS-  
Price / Sales ratio x1.74.0 42.7%   
Avg P/E ratio x21.427.7 77.2%  
P/CF ratio (eoy) x15.720.4 77.0%  
Price / Book Value ratio x2.45.2 46.1%  
Dividend payout %16.813.2 127.0%   
Avg Mkt Cap Rs m23,073707,513 3.3%   
No. of employees `0005.716.8 33.8%   
Total wages/salary Rs m2,55828,495 9.0%   
Avg. sales/employee Rs Th2,352.510,418.3 22.6%   
Avg. wages/employee Rs Th450.91,697.0 26.6%   
Avg. net profit/employee Rs Th190.41,523.0 12.5%   
INCOME DATA
Net Sales Rs m13,346174,943 7.6%  
Other income Rs m1921,065 18.0%   
Total revenues Rs m13,538176,008 7.7%   
Gross profit Rs m1,63944,931 3.6%  
Depreciation Rs m3909,122 4.3%   
Interest Rs m291,525 1.9%   
Profit before tax Rs m1,41235,349 4.0%   
Minority Interest Rs m0-72 0.0%   
Prior Period Items Rs m-483 -4.5%   
Extraordinary Inc (Exp) Rs m-350-   
Tax Rs m2939,785 3.0%   
Profit after tax Rs m1,08025,575 4.2%  
Gross profit margin %12.325.7 47.8%  
Effective tax rate %20.727.7 74.9%   
Net profit margin %8.114.6 55.4%  
BALANCE SHEET DATA
Current assets Rs m5,979119,542 5.0%   
Current liabilities Rs m2,43261,206 4.0%   
Net working cap to sales %26.633.3 79.7%  
Current ratio x2.52.0 125.9%  
Inventory Days Days6376 83.0%  
Debtors Days Days6090 67.2%  
Net fixed assets Rs m6,403131,660 4.9%   
Share capital Rs m182903 20.1%   
"Free" reserves Rs m9,293134,073 6.9%   
Net worth Rs m9,548134,976 7.1%   
Long term debt Rs m23056,478 0.4%   
Total assets Rs m12,843266,073 4.8%  
Interest coverage x50.024.2 207.0%   
Debt to equity ratio x00.4 5.8%  
Sales to assets ratio x1.00.7 158.0%   
Return on assets %8.610.2 84.8%  
Return on equity %11.318.9 59.7%  
Return on capital %14.319.3 74.4%  
Exports to sales %29.20-   
Imports to sales %6.30-   
Exports (fob) Rs m3,900NA-   
Imports (cif) Rs m847NA-   
Fx inflow Rs m4,35681,885 5.3%   
Fx outflow Rs m1,16221,506 5.4%   
Net fx Rs m3,19460,378 5.3%   
CASH FLOW
From Operations Rs m1,11941,148 2.7%  
From Investments Rs m-853-25,287 3.4%  
From Financial Activity Rs m-3344,332 -7.7%  
Net Cashflow Rs m-6820,193 -0.3%  

Share Holding

Indian Promoters % 50.1 46.6 107.5%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 15.1 11.3 133.6%  
FIIs % 3.0 31.9 9.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 10.1 313.9%  
Shareholders   20,176 98,259 20.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   CIPLA  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  SHASUN PHARMA  PFIZER  

Compare UNICHEM LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Share Markets Open Flat; Metal Stocks Witness Selling(09:30 am)

Asian stock markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.23% while the Hang Seng is down 0.49%. The Nikkei 225 is trading down by 0.55%.

Related Views on News

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

'Smart Money' Enters Bitcoin. Will You?(Smart Contrarian)

Jan 17, 2018

As institutional money enters bitcoin, the gains over the last year could just be the tip of the iceberg.

Increasing Divergence Between Bond Yields and Earnings Yield(Chart Of The Day)

Jan 11, 2018

Over the past couple of months, bond yields have risen, but earning yields have fallen, increasing divergence.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jan 24, 2018 11:31 AM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS